GSK PLC 2020 AR2
The report highlights GSK's resilient performance in 2020, delivering a group turnover of £34.1 billion despite the challenges of the COVID-19 pandemic. The company made significant progress in its pipeline with nine major regulatory approvals and advanced its preparation to separate into two standalone companies in 2022. In sustainability, GSK announced ambitious new environmental targets to achieve net-zero impact on climate and net-positive impact on nature by 2030. Additionally, the company topped the Access to Medicine Index for the seventh consecutive time and set new inclusion and diversity targets.
Company: GSK PLC
Sector: Manufacturing
Country: United Kingdom
Year: 2020
Type: AR2
Pages: 304
Back to company
GSK PLC
Annual Report
The report highlights GSK's resilient performance in 2020, delivering a group turnover of £34.1 billion despite the challenges of the COVID-19 pandemic. The company made significant progress in its pipeline with nine major regulatory approvals and advanced its preparation to separate into two standalone companies in 2022. In sustainability, GSK announced ambitious new environmental targets to achieve net-zero impact on climate and net-positive impact on nature by 2030. Additionally, the company topped the Access to Medicine Index for the seventh consecutive time and set new inclusion and diversity targets.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Jan 1, 2020 - Dec 31, 2020
Fiscal Year
2020
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target
Employees